Recently, two large studiesone involving a survey of more than 14,000 individuals in WeightWatchers telehealth weight management program, another being a retrospective observational study involving over 680,000 patients from two distinct study populationsfound an association between the prescription of GLP-1 agonist semaglutide (Wegovy) and a reduced risk for incident and AUD relapse among patients with either obesity or type-2 diabetes
Both medications have broadly similar side effect profiles dominated by GI symptoms nausea, vomiting, diarrhea, and constipation
Insert the Needle Pull the cap off your syringe
This gradual escalation continues in 2.5 mg increments through 7.5 mg, 10 mg, 12.5 mg, and up to the maximum dose of 15 mg per week
Legendary barbecue tradition featuring brisket, ribs, and all the fixings represents Dallas culinary pride beyond simple regional preference